FBXO42

Across TCGA pan-cancer cohorts, FBXO42 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of FBXO42’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where FBXO42 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types FBXO42 is over-expressed in tumor, although a few such as LSCC and LUAD show the opposite, repressed pattern.

LSCC, LUAD, and PDAC are the cancer types where FBXO42 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FBXO42 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	All	All	−0.098	<.001	6	view →
LUAD	All	All	−0.176	<.001	5	view →
PDAC	Male	All	−0.358	.025	4	view →
OV	All	All	−1.265	.007	2	view →
CCRCC	Male	II,III,IV	+0.162	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

FBXO42–LSCC

Open the LSCC breakdown →